The R61 will be an open trial to determine if Positive Processes and Transition to Health (PATH) engages the proposed targets: unproductive processing, avoidance, and reward deficits in a sample of 45 adults who have experienced a destabilizing life event involving profound loss or threat, report persistent stressor-related symptoms of PTSD and/or depression, and are elevated on symptoms related to 2 of the 3 therapeutic targets. Additionally, will examine whether patients perceive PATH as helpful and complete/adhere to treatment, and therapist fidelity. Patients will receive 6 sessions of PATH (with 2 boosters, if partial responders). Primary targets will be assessed at pre-treatment, week 4, post-treatment, and at 1- and 3-month follow-up; secondary targets at pre-treatment, weekly during treatment, post-treatment, and at 1- and 3-month follow-ups.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Affective Updating Task (Pe et al., 2013; Pe, Raes, et al., 2013)
Timeframe: Score at 6 weeks (immediately post treatment)
Idiographic Behavioral Approach Task
Timeframe: Score at 6 weeks (immediately post treatment)
Probabilistic Reward Task (Pizzagalli et al., 2005)
Timeframe: Score at 6 weeks (immediately post treatment)